U.S. Capital Wealth Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.84M | Buy |
256,307
+15,336
| +6% | +$589K | 0.29% | 84 |
|
|
2025
Q1 | $9.34M | Buy |
240,971
+23,648
| +11% | +$916K | 0.29% | 88 |
|
|
2024
Q4 | $7.35M | Sell |
217,323
-25,722
| -11% | -$870K | 0.23% | 109 |
|
|
2024
Q3 | $9.94M | Buy |
243,045
+1,072
| +0.4% | +$43.8K | 0.35% | 68 |
|
|
2024
Q2 | $9.32M | Buy |
241,973
+11,359
| +5% | +$437K | 0.35% | 64 |
|
|
2024
Q1 | $9.89M | Sell |
230,614
-2,957
| -1% | -$127K | 0.38% | 57 |
|
|
2023
Q4 | $8.66M | Buy |
233,571
+12,443
| +6% | +$461K | 0.34% | 66 |
|
|
2023
Q3 | $8.02M | Buy |
221,128
+27,753
| +14% | +$1.01M | 0.36% | 60 |
|
|
2023
Q2 | $6.89M | Buy |
193,375
+27,908
| +17% | +$995K | 0.33% | 78 |
|
|
2023
Q1 | $5.89M | Sell |
165,467
-1,308
| -0.8% | -$46.5K | 0.27% | 84 |
|
|
2022
Q4 | $5.86M | Sell |
166,775
-42,203
| -20% | -$1.48M | 0.27% | 82 |
|
|
2022
Q3 | $6.15M | Buy |
208,978
+22,256
| +12% | +$655K | 0.31% | 74 |
|
|
2022
Q2 | $10.2M | Buy |
186,722
+6,324
| +4% | +$344K | 0.45% | 39 |
|
|
2022
Q1 | $9.82M | Buy |
180,398
+15,743
| +10% | +$857K | 0.36% | 51 |
|
|
2021
Q4 | $9.08M | Buy |
164,655
+4,604
| +3% | +$254K | 0.36% | 65 |
|
|
2021
Q3 | $7.64M | Buy |
+160,051
| New | +$7.64M | 0.33% | 72 |
|